Skip to main content
. 2020 Nov 22;12(11):e11621. doi: 10.7759/cureus.11621

Figure 4. Forest plot showing the change in monthly migraine headache days with acute medication use between galcanezumab and placebo groups before (A) and after (B) sensitivity analysis using the leave-one-out method.

Figure 4